跳至主要内容
临床试验/NCT06724055
NCT06724055已完成不适用

Diagnostic Prediction of Pancreatic Masses: How to Avoid an Unnecessary Resection

Peking Union Medical College Hospital0 个研究点目标入组 110 人开始时间: 2002年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
110
主要终点
Diagnostic nomogram

研究概览

简要总结

The goal of this observational study is to learn if a strategy can be developed for differentiating autoimmune pancreatitis (AIP) and primary pancreatic lymphoma (PPL) from pancreatic ductal adenocarcinoma (PDAC) in patients presenting with pancreatic masses. The main question it aims to answer is:

What features, in the perspectives of clinical manifestation, laboratory tests, and imaging, can differentiate different kinds of pancreatic masses (AIP, PPL and PDAC)?

Participants will not be given any interventions since this is a retrospective observational study.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Inpatients presenting with pancreatic masses and eventually diagnosed with PPL, AIP, or PDAC (confirmed by pathologic results).

排除标准

  • 未提供

结局指标

主要结局

Diagnostic nomogram

时间窗: From date of admission into the hospital to the establishment of diagnosis, assessed up to 100 months

次要结局

  • serum level of LDH(From date of admission into the hospital to the establishment of diagnosis, assessed up to 100 months)
  • serum level of IgG4(From date of admission into the hospital to the establishment of diagnosis, assessed up to 100 months)
  • largest diameter of pancreatic masses(From date of admission into the hospital to the establishment of diagnosis, assessed up to 100 months)
  • dilation of pancreatic duct(From date of admission into the hospital to the establishment of diagnosis, assessed up to 100 months)

研究者

申办方类型
Other
责任方
Sponsor

相似试验